30-day Notice

36612

Federal Register / Vol. 84, No. 145 / Monday, July 29, 2019 / Notices
2019. The closed session is amended to
end at 9:30 a.m. and the open session is
amended to begin at 9:30 a.m. The
meeting is partially closed to the public.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

National Institutes of Health

National Institutes of Health

National Institute on Drug Abuse;
Notice of Closed Meeting

National Institute on Alcohol Abuse
and Alcoholism; Amended Notice of
Meeting

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The cooperative agreement
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the cooperative agreement applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.

Notice is hereby given of a change in
the meeting of the Board of Scientific
Counselors, NIAAA, September 18,
2019, 8:30 a.m. to September 18, 2019,
3:30 p.m., National Institutes of Health,
Building 10, Conference Room I–2330,
10 Center Drive, Bethesda, MD 20892
which was published in the Federal
Register on February 26, 2019, 84 FR
6155.
This meeting notice is amended to
change the meeting location from
Building 10, Conference Room I–2330,
10 Center Drive, Bethesda, MD 20892 to
5625 Fishers Lane, 5th Floor Conference
Room, Rockville, MD 20852. The
meeting is closed to the public.

Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Development of Medications to Prevent and
Treat Opioid Use Disorders and Overdose
(UG3/UH3—Clinical Trials Optional).
Date: August 22, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Ivan K. Navarro, Ph.D.,
Scientific Review Officer, Office of
Extramural Policy and Review, Division of
Extramural Research, National Institute on
Drug Abuse, NIH, DHHS, 6001 Executive
Boulevard, Room 4242, MSC 9550, Bethesda,
MD 20892, 301–827–5833, ivan.navarro@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: July 24, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–16021 Filed 7–26–19; 8:45 am]
BILLING CODE 4140–01–P

Dated: July 24, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–16020 Filed 7–26–19; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request National Cancer
Institute (NCI) a Generic Submission
for Formative Research, Pretesting and
Customer Satisfaction of NCI’s
Communication and Education
Resources (NCI); Correction
AGENCY:

Dated: July 24, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.

National Institutes of Health,

HHS.
ACTION:

Notice; correction.

The Department of Health and
Human Services, National Institutes of
Health published a Notice in the
Federal Register on July 2, 2019. That
Notice requires a correction in the
SUPPLEMENTARY INFORMATION section.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Ilene French,
Branch Chief, Office of Communication
and Public Liaison, National Cancer
Institute, 9609 Medical Center Drive,
Maryland, 20892 or call non-toll-free
number (240) 276–7787 or Email your
request, including your address to:
nciocpl@mail.nih.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:

[FR Doc. 2019–16013 Filed 7–26–19; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Amended Notice of
Meeting
Notice is hereby given of a change in
the meeting of the National Advisory
Council on Alcohol Abuse and
Alcoholism, September 19, 2019, 9:00
a.m. to September 19, 2019, 3:00 p.m.,
National Institutes of Health, National
Institute on Alcohol Abuse and
Alcoholism, 6700B Rockledge Drive,
Bethesda, MD 20817 which was
published in the Federal Register on
February 05, 2019, 84 FR 1757.
This meeting notice is amended to
change the meeting date from
September 19, 2019 to September 12,

Correction
In the Federal Register of July 2,
2019, in FR Doc. 2019–14071, on page
31605, correct the Estimated
Annualized Burden Hours table to read
as follows:

khammond on DSKBBV9HB2PROD with NOTICES

ESTIMATED ANNUALIZED BURDEN HOURS
Form name

Type of
respondents

Focus Groups, Individual In-Depth Interviews, Brief Interviews, Surveys, Website Usability Testing.

Individuals .....
(General Public).

VerDate Sep<11>2014

16:54 Jul 26, 2019

Jkt 247001

PO 00000

Frm 00048

Fmt 4703

Number of
respondents

Sfmt 4703

Number of
responses per
respondent

9,000

E:\FR\FM\29JYN1.SGM

1

29JYN1

Average time
per response
(in hours)
45/60

Total annual
burden hours
6,750

36613

Federal Register / Vol. 84, No. 145 / Monday, July 29, 2019 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued

Focus Groups, Individual In-Depth Interviews, Brief Interviews, Surveys, Website Usability Testing.

Individuals .....
(Health Care
Professionals).

9,000

1

45/60

6,750

Total ..............................................................................

.......................

........................

18,000

........................

13,500

[FR Doc. 2019–16022 Filed 7–26–19; 8:45 am]
BILLING CODE 4140–01–P

(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: July 24, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health

[FR Doc. 2019–16015 Filed 7–26–19; 8:45 am]
BILLING CODE 4140–01–P

National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.

khammond on DSKBBV9HB2PROD with NOTICES

Average time
per response
(in hours)

Type of
respondents

Dated: July 24, 2019.
Patricia M. Busche,
Project Clearance Liaison, National Cancer
Institute, National Institutes of Health.

Number of
respondents

Number of
responses per
respondent

Form name

Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Chronic Kidney
Disease Biomarkers Consortium
Applications.
Date: August 15, 2019.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Ryan G. Morris, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7015, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, 301–594–4721,
ryan.morris@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.

VerDate Sep<11>2014

16:54 Jul 26, 2019

Jkt 247001

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Eye Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Eye Institute
Special Emphasis Panel; BRAIN Initiative:
New Concepts and Early-Stage Research for
Large-Scale Recording and Modulation in the
Nervous System (R21).
Date: August 29, 2019.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817
(Virtual Meeting).
Contact Person: Brian Hoshaw, Ph.D.,
Acting Review Chief, National Eye Institute,
National Institutes of Health, Division of
Extramural Research, 6700B Rockledge Dr.,
Ste. 3400, Rockville, MD 20892, 301–451–
2020, hoshawb@mail.nih.gov.

PO 00000

Frm 00049

Fmt 4703

Sfmt 4703

Total annual
burden hours

(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
Dated: July 24, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–16017 Filed 7–26–19; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Physical
Frailty II [2020/01 ZAG1 ZIJ–P (J3)].
Date: September 26, 2019.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Nijaguna Prasad, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, 7201
Wisconsin Avenue, Gateway Building, Suite
2W200, Bethesda, MD 20892, 301–496–9667,
nijaguna.prasad@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)

E:\FR\FM\29JYN1.SGM

29JYN1